hexamethonium has been researched along with argipressin, deaminopenicillamine(1)-val(4)- in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, J; Hirata, M; Itho, H; Kawasaki, S; Nakagawa, M; Nakata, T; Oguro, M; Sasaki, S; Takeda, K | 1 |
1 other study(ies) available for hexamethonium and argipressin, deaminopenicillamine(1)-val(4)-
| Article | Year |
|---|---|
Paraventricular nucleus lesions attenuate the development of hypertension in DOCA/salt-treated rats.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Desoxycorticosterone; Epinephrine; Hexamethonium; Hexamethonium Compounds; Hypertension; Male; Norepinephrine; Paraventricular Hypothalamic Nucleus; Rats; Rats, Inbred Strains | 1989 |